Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine M Greene

Showing results (21-30 of 144) with videos related to

Pageof 15
Sort By:
Expert Review of Molecular Diagnostics|November 20, 2015
High-throughput profiling for discovery of non-coding RNA biomarkers of lung diseasePaul J McKiernan, Catherine M Greene
Journal of Innate Immunity|April 5, 2016
Toll-Like Receptors in Cystic Fibrosis: Impact of Dysfunctional microRNA on Innate Immune Responses in the Cystic Fibrosis LungSebastian F Vencken, Catherine M Greene
Mediators of Inflammation|July 18, 2015
MicroRNA Dysregulation in Cystic FibrosisPaul J McKiernan, Catherine M Greene
Expert Review of Respiratory Medicine|July 14, 2022
Epithelial damage in the cystic fibrosis lung: the role of host and microbial factorsArlene M A Glasgow, Catherine M Greene
Non-Coding RNA|January 17, 2023
Long Non-Coding RNA Expression in Alpha-1 Antitrypsin Deficient Monocytes Pre- and Post-AAT Augmentation TherapyStephen G J Smith, Catherine M Greene
Biologics : Targets & Therapy|August 27, 2009
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiencyCaitriona McLean, Catherine M Greene, Noel G McElvaney
Expert Opinion on Therapeutic Targets|January 23, 2008
Targeting neutrophil elastase in cystic fibrosisEmer Kelly, Catherine M Greene, Noel G McElvaney
Expert Opinion on Therapeutic Targets|November 15, 2008
Toll-like receptors as therapeutic targets in cystic fibrosisCatherine M Greene, Peter Branagan, Noel G McElvaney
Nutrients|March 13, 2013
Is there a therapeutic role for selenium in alpha-1 antitrypsin deficiency?Catherine M Greene, Roohi Chhabra, Noel G McElvaney
Biochemical Society Transactions|September 23, 2011
SLPI and inflammatory lung disease in femalesPaul J McKiernan, Noel G McElvaney, Catherine M Greene
Pageof 15

Showing results (21-30 of 144) with videos related to

Sort By:
Pageof 15
Expert Review of Molecular Diagnostics|November 20, 2015
High-throughput profiling for discovery of non-coding RNA biomarkers of lung diseasePaul J McKiernan, Catherine M Greene
Journal of Innate Immunity|April 5, 2016
Toll-Like Receptors in Cystic Fibrosis: Impact of Dysfunctional microRNA on Innate Immune Responses in the Cystic Fibrosis LungSebastian F Vencken, Catherine M Greene
Mediators of Inflammation|July 18, 2015
MicroRNA Dysregulation in Cystic FibrosisPaul J McKiernan, Catherine M Greene
Expert Review of Respiratory Medicine|July 14, 2022
Epithelial damage in the cystic fibrosis lung: the role of host and microbial factorsArlene M A Glasgow, Catherine M Greene
Non-Coding RNA|January 17, 2023
Long Non-Coding RNA Expression in Alpha-1 Antitrypsin Deficient Monocytes Pre- and Post-AAT Augmentation TherapyStephen G J Smith, Catherine M Greene
Biologics : Targets & Therapy|August 27, 2009
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiencyCaitriona McLean, Catherine M Greene, Noel G McElvaney
Expert Opinion on Therapeutic Targets|January 23, 2008
Targeting neutrophil elastase in cystic fibrosisEmer Kelly, Catherine M Greene, Noel G McElvaney
Expert Opinion on Therapeutic Targets|November 15, 2008
Toll-like receptors as therapeutic targets in cystic fibrosisCatherine M Greene, Peter Branagan, Noel G McElvaney
Nutrients|March 13, 2013
Is there a therapeutic role for selenium in alpha-1 antitrypsin deficiency?Catherine M Greene, Roohi Chhabra, Noel G McElvaney
Biochemical Society Transactions|September 23, 2011
SLPI and inflammatory lung disease in femalesPaul J McKiernan, Noel G McElvaney, Catherine M Greene
Pageof 15